MSFT   210.40 (+1.03%)
AMZN   3,056.00 (+1.86%)
AMD   52.40 (-1.00%)
ACB   12.38 (-0.32%)
F   6.12 (+0.00%)
GILD   76.53 (+0.14%)
DIS   114.21 (+0.51%)
BAC   22.96 (-0.26%)
MSFT   210.40 (+1.03%)
AMZN   3,056.00 (+1.86%)
AMD   52.40 (-1.00%)
ACB   12.38 (-0.32%)
F   6.12 (+0.00%)
GILD   76.53 (+0.14%)
DIS   114.21 (+0.51%)
BAC   22.96 (-0.26%)
MSFT   210.40 (+1.03%)
AMZN   3,056.00 (+1.86%)
AMD   52.40 (-1.00%)
ACB   12.38 (-0.32%)
F   6.12 (+0.00%)
GILD   76.53 (+0.14%)
DIS   114.21 (+0.51%)
BAC   22.96 (-0.26%)
MSFT   210.40 (+1.03%)
AMZN   3,056.00 (+1.86%)
AMD   52.40 (-1.00%)
ACB   12.38 (-0.32%)
F   6.12 (+0.00%)
GILD   76.53 (+0.14%)
DIS   114.21 (+0.51%)
BAC   22.96 (-0.26%)
Log in

Compare Healthcare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Johnson & JohnsonMerck & Co., Inc.PfizerNovartisUnitedHealth Group
SymbolNYSE:JNJNYSE:MRKNYSE:PFENYSE:NVSNYSE:UNH
Price Information
Current Price$142.97$78.74$34.17$87.95$299.14
52 Week RangeBuyBuyHoldHoldBuy
Beat the Market™ Rank
Overall Score2.42.32.71.82.5
Analysis Score3.43.43.23.12.4
Community Score2.42.52.92.33.4
Dividend Score4.23.35.02.54.2
Ownership Score1.01.01.00.01.0
Earnings & Valuation Score1.31.31.31.31.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$163.86$94.15$38.61$107.00$327.09
% Upside from Price Target14.61% upside19.58% upside12.99% upside21.66% upside9.34% upside
Trade Information
Market Cap$376.01 billion$198.57 billion$189.03 billion$200.95 billion$281.34 billion
Beta0.690.480.680.50.72
Average Volume7,376,44810,337,28633,425,0401,715,6453,375,094
Sales & Book Value
Annual Revenue$82.06 billion$46.84 billion$51.75 billion$47.50 billion$242.16 billion
Price / Sales4.594.243.674.241.17
Cashflow$11.52 per share$6.62 per share$4.07 per share$7.85 per share$18.05 per share
Price / Cash12.4111.898.4011.2016.57
Book Value$22.60 per share$10.21 per share$11.46 per share$24.53 per share$63.79 per share
Price / Book6.337.712.983.594.69
Profitability
Net Income$15.12 billion$9.84 billion$16.27 billion$11.73 billion$13.84 billion
EPS$8.68$5.19$2.95$5.24$15.11
Trailing P/E Ratio18.9119.9312.2016.7820.93
Forward P/E Ratio15.6813.6912.5214.0716.30
P/E Growth$3.12$2.22$2.70$1.95$1.49
Net Margins24.47%21.10%31.17%24.97%5.59%
Return on Equity (ROE)39.71%52.46%25.76%24.39%24.86%
Return on Assets (ROA)15.27%16.67%9.91%10.84%8.26%
Dividend
Annual Payout$4.04$2.44$1.52$2.01$5.00
Dividend Yield2.83%3.10%4.45%2.29%1.67%
Three-Year Dividend Growth588.07%101.79%369.57%N/A110,300.00%
Payout Ratio46.54%47.01%51.53%38.36%33.09%
Years of Consecutive Dividend Growth57 Years8 Years10 Years1 Years10 Years
Debt
Debt-to-Equity Ratio0.41%0.82%0.56%0.50%0.60%
Current Ratio1.31%1.11%1.02%0.74%0.75%
Quick Ratio1.05%0.87%0.78%0.53%0.75%
Ownership Information
Institutional Ownership Percentage68.51%74.33%70.28%10.79%86.59%
Insider Ownership Percentage0.27%0.28%0.08%0.01%0.80%
Miscellaneous
Employees132,20071,00088,300103,914325,000
Shares Outstanding2.63 billion2.52 billion5.55 billion2.29 billion948.38 million
Next Earnings Date7/16/2020 (Confirmed)7/31/2020 (Confirmed)7/28/2020 (Confirmed)7/21/2020 (Confirmed)7/15/2020 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.